|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
JPS59156299A
(ja)
|
1983-02-28 |
1984-09-05 |
Noda Sangyo Kagaku Kenkyusho |
Ｎ−アセチルヘキソサミンの定量法及びその定量用試薬
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4534972A
(en)
|
1983-03-29 |
1985-08-13 |
Miles Laboratories, Inc. |
Protein compositions substantially free from infectious agents
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US5045468A
(en)
*
|
1986-12-12 |
1991-09-03 |
Cell Enterprises, Inc. |
Protein-free culture medium which promotes hybridoma growth
|
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
DE68925971T2
(de)
|
1988-09-23 |
1996-09-05 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
|
US6048728A
(en)
*
|
1988-09-23 |
2000-04-11 |
Chiron Corporation |
Cell culture medium for enhanced cell growth, culture longevity, and product expression
|
|
JP2989002B2
(ja)
|
1988-12-22 |
1999-12-13 |
キリン―アムジエン・インコーポレーテツド |
化学修飾顆粒球コロニー刺激因子
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
US5110913A
(en)
*
|
1990-05-25 |
1992-05-05 |
Miles Inc. |
Antibody purification method
|
|
US5096816A
(en)
*
|
1990-06-05 |
1992-03-17 |
Cetus Corporation |
In vitro management of ammonia's effect on glycosylation of cell products through pH control
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
JPH06508511A
(ja)
|
1990-07-10 |
1994-09-29 |
ケンブリッジ アンティボディー テクノロジー リミティド |
特異的な結合ペアーの構成員の製造方法
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
DE69233769D1
(de)
|
1991-03-01 |
2009-09-24 |
Dyax Corp |
Chimäres Protein mit Mikroprotein mit zwei oder mehr Disulfidbindungen und Ausgestaltungen davon
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
EP0666312A1
(en)
*
|
1994-02-08 |
1995-08-09 |
Wolfgang A. Renner |
Process for the improvement of mammalian cell growth
|
|
US5429746A
(en)
*
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
|
US5853714A
(en)
*
|
1995-03-27 |
1998-12-29 |
Genetics Institute, Inc. |
Method for purification of IL-12
|
|
US5641870A
(en)
*
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US6656466B1
(en)
*
|
1995-06-06 |
2003-12-02 |
Genetech, Inc. |
Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
|
|
US5721121A
(en)
*
|
1995-06-06 |
1998-02-24 |
Genentech, Inc. |
Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
|
|
US5705364A
(en)
*
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
JP4306813B2
(ja)
*
|
1995-09-19 |
2009-08-05 |
アスビオファーマ株式会社 |
動物細胞の新規培養方法
|
|
ATE222598T1
(de)
*
|
1996-04-19 |
2002-09-15 |
Nestle Sa |
Menschliche immortalisierte colon- epithelialzellen
|
|
AU5082698A
(en)
|
1996-10-23 |
1998-05-15 |
Oravax, Inc |
Heat inactivation of viruses in antibody preparations
|
|
WO1998022137A1
(en)
*
|
1996-11-15 |
1998-05-28 |
The Kennedy Institute Of Rheumatology |
SUPPRESSION OF TNF α AND IL-12 IN THERAPY
|
|
DE69739673D1
(de)
*
|
1996-11-27 |
2009-12-31 |
Genentech Inc |
Affinitätsreinigung von Polypeptid-Proteinen auf einer Protein A Matrix
|
|
US6955917B2
(en)
*
|
1997-06-20 |
2005-10-18 |
Bayer Healthcare Llc |
Chromatographic method for high yield purification and viral inactivation of antibodies
|
|
IL121900A
(en)
|
1997-10-07 |
2001-12-23 |
Omrix Biopharmaceuticals Ltd |
A method for the purification of immunoglobulins
|
|
US20020045207A1
(en)
*
|
1997-10-31 |
2002-04-18 |
Lynne A. Krummen |
Glycoprotein production process
|
|
WO1999032605A1
(en)
|
1997-12-19 |
1999-07-01 |
Novo Nordisk A/S |
Method for producing heterologous proteins in eukaryotic cells on an industrial scale using nucleotide-manipulating agents
|
|
ES2292682T3
(es)
*
|
1998-05-06 |
2008-03-16 |
Genentech, Inc. |
Purificacion de anticuerpos mediante cromatografia de intercambio ionico.
|
|
US6528286B1
(en)
*
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
CA2384880C
(en)
*
|
1999-09-27 |
2010-09-21 |
Genentech, Inc. |
Methods for making recombinant proteins using apoptosis inhibitors
|
|
DE60120356T2
(de)
*
|
2000-02-08 |
2007-06-14 |
Genentech, Inc., South San Francisco |
Verbesserte galactosylierung von rekombinanten proteinen
|
|
TWI373343B
(en)
|
2000-02-10 |
2012-10-01 |
Abbott Gmbh & Co Kg |
Antibodies that bind human interleukin-18 and methods of making and using
|
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
EP1175931A1
(en)
*
|
2000-07-25 |
2002-01-30 |
Computer Cell Culture Center S.A. |
Integration of high cell density bioreactor operation with ultra fast on-line downstream processing
|
|
AU2001294520A1
(en)
*
|
2000-08-21 |
2002-03-04 |
Clonex Development, Inc. |
Methods and compositions for increasing protein yield from a cell culture
|
|
US6693173B2
(en)
*
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
|
US20030096414A1
(en)
*
|
2001-03-27 |
2003-05-22 |
Invitrogen Corporation |
Culture medium for cell growth and transfection
|
|
CN1789416B
(zh)
|
2001-05-11 |
2011-11-16 |
协和发酵麒麟株式会社 |
含人抗体λ轻链基因的人类人工染色体
|
|
WO2002098531A1
(en)
*
|
2001-06-05 |
2002-12-12 |
Genetics Institute, Llc |
Methods for purifying highly anionic proteins
|
|
RU2321630C2
(ru)
*
|
2001-08-03 |
2008-04-10 |
Гликарт Биотекнолоджи АГ |
Гликозилированные антитела (варианты), обладающие повышенной антителозависимой клеточной цитотоксичностью
|
|
HUP0402158A2
(hu)
*
|
2001-10-02 |
2005-01-28 |
Novo Nordisk Health Care Ag |
Rekombináns fehérjék előállítási eljárása eukarióta sejtekben
|
|
US20030157108A1
(en)
*
|
2001-10-25 |
2003-08-21 |
Genentech, Inc. |
Glycoprotein compositions
|
|
IL161858A0
(en)
|
2001-11-28 |
2005-11-20 |
Sandoz Ag |
Cell culture process
|
|
MXPA04006053A
(es)
*
|
2001-12-21 |
2005-03-31 |
Immunex Corp |
Metodos para purificacion de proteina.
|
|
US20030201229A1
(en)
*
|
2002-02-04 |
2003-10-30 |
Martin Siwak |
Process for prefiltration of a protein solution
|
|
ATE417858T1
(de)
*
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
|
CA2417689C
(en)
*
|
2002-03-05 |
2006-05-09 |
F. Hoffmann-La Roche Ag |
Improved methods for growing mammalian cells in vitro
|
|
US20030190710A1
(en)
*
|
2002-03-28 |
2003-10-09 |
Devries Ruth L. |
Control of glycoforms in IgG
|
|
US20040132140A1
(en)
*
|
2002-04-09 |
2004-07-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Production process for antibody composition
|
|
RU2304587C2
(ru)
*
|
2002-06-10 |
2007-08-20 |
Гуд Байотек Копэрейшн |
СПОСОБ СЕЛЕКТИВНОГО ВЫДЕЛЕНИЯ АНТИТЕЛ IgY ИЗ ЯИЧНОГО ЖЕЛТКА ПТИЦ ОТРЯДА ГУСЕОБРАЗНЫХ (ВАРИАНТЫ)
|
|
ES2285188T3
(es)
*
|
2002-07-15 |
2007-11-16 |
Immunex Corporation |
Metodo y medios para controlar sialilacion de proteinas producidas por celulas de mamifero.
|
|
AR040603A1
(es)
*
|
2002-07-19 |
2005-04-13 |
Abbott Lab S A |
El uso de un anticuerpo anti-tnfalfa neutralizador de alta afinidad en la fabricacion de un medicamento y conjunto de elementos
|
|
US7067279B1
(en)
*
|
2002-08-23 |
2006-06-27 |
Immunex Corporation |
Cell culture performance with betaine
|
|
US6974681B1
(en)
*
|
2002-08-23 |
2005-12-13 |
Immunex Corporation |
Cell culture performance with vanadate
|
|
WO2004026427A2
(en)
|
2002-09-17 |
2004-04-01 |
Gtc Biotherapeutics, Inc. |
Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
|
|
US7208585B2
(en)
*
|
2002-09-18 |
2007-04-24 |
Genencor International, Inc. |
Protein purification
|
|
US20040162414A1
(en)
|
2002-11-22 |
2004-08-19 |
Santora Ling C. |
Method for reducing or preventing modification of a polypeptide in solution
|
|
JP4541157B2
(ja)
*
|
2002-12-23 |
2010-09-08 |
ブリストル−マイヤーズ スクイブ カンパニー |
タンパク質を製造するための哺乳類細胞培養法
|
|
DE60335024D1
(de)
*
|
2002-12-23 |
2010-12-30 |
Bristol Myers Squibb Co |
Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion
|
|
PT1623019E
(pt)
*
|
2003-05-15 |
2010-07-20 |
Wyeth Llc |
ALIMENTAÃO COM GLUCOSE DE MODO LIMITADO PARA CULTURA DE CéLULAS ANIMAIS
|
|
PT3095793T
(pt)
*
|
2003-07-28 |
2020-05-04 |
Genentech Inc |
Redução da lixiviação de proteína a durante a cromatografia por afinidade com proteína a
|
|
GB2404665B
(en)
*
|
2003-08-08 |
2005-07-06 |
Cambridge Antibody Tech |
Cell culture
|
|
WO2005035748A1
(en)
*
|
2003-10-10 |
2005-04-21 |
Novo Nordisk Health Care Ag |
Method for large-scale production of a polypeptide in eukaryote cells and a culture vessel suitable therefor
|
|
PT1678208E
(pt)
*
|
2003-10-27 |
2013-07-10 |
Wyeth Llc |
Remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatite
|
|
US8084032B2
(en)
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
|
SE0400886D0
(sv)
*
|
2004-04-02 |
2004-04-02 |
Amersham Biosciences Ab |
Process of purification
|
|
US20060127950A1
(en)
*
|
2004-04-15 |
2006-06-15 |
Massachusetts Institute Of Technology |
Methods and products related to the improved analysis of carbohydrates
|
|
EP1745141B2
(en)
|
2004-05-04 |
2019-09-25 |
Novo Nordisk Health Care AG |
O-linked glycoforms of faktor vii and method to manufacture them
|
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
|
EP1807101B1
(en)
*
|
2004-09-30 |
2016-04-13 |
Bayer Healthcare LLC |
Devices and methods for integrated continuous manufacturing of biological molecules
|
|
US20060094104A1
(en)
|
2004-10-29 |
2006-05-04 |
Leopold Grillberger |
Animal protein-free media for cultivation of cells
|
|
JP2006143601A
(ja)
*
|
2004-11-16 |
2006-06-08 |
Yamato Yakuhin Kk |
血液粘度低下剤
|
|
US8728828B2
(en)
*
|
2004-12-22 |
2014-05-20 |
Ge Healthcare Bio-Sciences Ab |
Purification of immunoglobulins
|
|
US8530192B2
(en)
|
2005-02-11 |
2013-09-10 |
Novo Nordisk Healthcare Ag |
Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate
|
|
WO2006099308A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Wyeth |
A method of weak partitioning chromatography
|
|
EP1869067A1
(en)
|
2005-04-11 |
2007-12-26 |
Medarex, Inc. |
Protein purification using hcic amd ion exchange chromatography
|
|
WO2006113743A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Massachusetts Institute Of Technology |
Compositions and methods for rna interference with sialidase expression and uses thereof
|
|
US7247457B2
(en)
*
|
2005-04-26 |
2007-07-24 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Detection and identification of enteroviruses by semi-nested amplification of the enterovirus VP1 protein
|
|
EP1888638A2
(en)
*
|
2005-06-03 |
2008-02-20 |
Genentech, Inc. |
Method of producing antibodies with modified fucosylation level
|
|
ES2776657T3
(es)
*
|
2005-06-14 |
2020-07-31 |
Amgen Inc |
Formulaciones de proteínas autotamponantes
|
|
ES2402650T3
(es)
*
|
2005-06-17 |
2013-05-07 |
Janssen Alzheimer Immunotherapy |
Métodos de purificación de anticuerpos anti A beta
|
|
SG155183A1
(en)
*
|
2005-08-26 |
2009-09-30 |
Ares Trading Sa |
Process for the preparation of glycosylated interferon beta
|
|
AR058140A1
(es)
*
|
2005-10-24 |
2008-01-23 |
Wyeth Corp |
Metodo de produccion proteica utilizando compuestos anti-senescencia
|
|
US7972810B2
(en)
*
|
2005-12-08 |
2011-07-05 |
Amgen Inc. |
Production of glycoproteins using manganese
|
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
|
MX2008012896A
(es)
*
|
2006-04-05 |
2008-10-14 |
Abbott Biotech Ltd |
Purificacion de anticuerpos.
|
|
RU2008150314A
(ru)
*
|
2006-05-19 |
2010-06-27 |
Гликофи, Инк. (Us) |
Композиции эритропоэтина
|
|
WO2009017491A1
(en)
*
|
2006-06-14 |
2009-02-05 |
Smithkline Beecham Corporation |
Methods for purifying antibodies using ceramic hydroxyapatite
|
|
WO2008007280A2
(en)
|
2006-06-28 |
2008-01-17 |
Koninklijke Philips Electronics N.V. |
Assay system and method
|
|
DK3255141T3
(da)
|
2006-07-13 |
2022-01-31 |
Wyeth Llc |
Fremstilling af antistoffer med forbedret glycosyleringsmønster
|
|
FI2061803T4
(fi)
*
|
2006-08-28 |
2023-03-14 |
|
Process for the purification of fc-containing proteins
|
|
CL2007002615A1
(es)
*
|
2006-09-08 |
2008-04-18 |
Wyeth Corp |
Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto.
|
|
US8911964B2
(en)
*
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
BRPI0716762A2
(pt)
*
|
2006-09-13 |
2013-09-24 |
Abbott Lab |
melhorias da cultura celular
|
|
WO2008036600A2
(en)
*
|
2006-09-18 |
2008-03-27 |
Genentech, Inc. |
Methods of protein production
|
|
WO2008036899A2
(en)
|
2006-09-22 |
2008-03-27 |
Amgen Inc. |
Methods for removing viral contaminants during protein purification
|
|
EP2395077A1
(en)
*
|
2006-11-03 |
2011-12-14 |
Wyeth LLC |
Glycolysis-inhibiting substances in cell culture
|
|
WO2008068879A1
(en)
|
2006-12-06 |
2008-06-12 |
Jcr Pharmaceuticals Co., Ltd. |
Method for production of human erythropoietin
|
|
US8163886B2
(en)
*
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
|
JP5586235B2
(ja)
*
|
2007-03-02 |
2014-09-10 |
ワイス・エルエルシー |
ポリペプチドの産生のための細胞培養における銅およびグルタミン酸塩の使用
|
|
US7935808B2
(en)
*
|
2007-03-30 |
2011-05-03 |
Abbott Laboratories |
Recombinant expression vector elements (rEVEs) for enhancing expression of recombinant proteins in host cells
|
|
AU2008232903B9
(en)
*
|
2007-03-30 |
2013-09-05 |
Medimmune Llc |
Antibodies with decreased deamidation profiles
|
|
CA2887752C
(en)
*
|
2007-04-03 |
2020-03-24 |
Vib Vzw |
Glycosylation of molecules
|
|
CA2682738A1
(en)
|
2007-04-16 |
2008-10-23 |
Momenta Pharmaceuticals, Inc. |
Defined glycoprotein products and related methods
|
|
TW200902708A
(en)
*
|
2007-04-23 |
2009-01-16 |
Wyeth Corp |
Methods of protein production using anti-senescence compounds
|
|
EP1988101A1
(en)
|
2007-05-04 |
2008-11-05 |
Novo Nordisk A/S |
Improvement of factor VIII polypeptide titers in cell cultures
|
|
WO2008135498A2
(en)
|
2007-05-04 |
2008-11-13 |
Novo Nordisk A/S |
Prevention of protein degradation in mammalian cell cultures
|
|
WO2008141207A1
(en)
|
2007-05-11 |
2008-11-20 |
Amgen Inc. |
Improved feed media
|
|
WO2008154014A2
(en)
*
|
2007-06-11 |
2008-12-18 |
Amgen Inc. |
A method for culturing mammalian cells to improve recombinant protein production
|
|
MX354993B
(es)
*
|
2007-07-09 |
2018-03-28 |
Genentech Inc |
Prevención de reducción de enlaces de disulfuro durante la producción recombinante de polipéptidos.
|
|
ES2657055T3
(es)
|
2007-08-09 |
2018-03-01 |
Wyeth Llc |
Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
|
|
BRPI0817182A2
(pt)
|
2007-10-30 |
2015-03-17 |
Genentech Inc |
Método para purificar um anticorpo e composições
|
|
WO2009058769A1
(en)
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
|
TWM332870U
(en)
*
|
2007-11-22 |
2008-05-21 |
Delta Electronics Inc |
Side-edge type backlight module
|
|
NZ622583A
(en)
*
|
2007-11-30 |
2015-08-28 |
Abbvie Biotechnology Ltd |
Protein formulations and methods of making same
|
|
AU2008345231B2
(en)
|
2007-12-27 |
2014-09-11 |
Takeda Pharmaceutical Company Limited |
Cell culture processes
|
|
WO2009092014A1
(en)
*
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
AU2009223054A1
(en)
*
|
2008-03-11 |
2009-09-17 |
Genentech, Inc. |
Antibodies with enhanced ADCC function
|
|
PT2271382E
(pt)
*
|
2008-04-15 |
2013-05-07 |
Grifols Therapeutics Inc |
Ultrafiltração em dois andares/diafiltração
|
|
ES2458541T5
(en)
*
|
2008-05-02 |
2025-08-04 |
Seagen Inc |
Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
|
|
WO2010016943A2
(en)
|
2008-08-08 |
2010-02-11 |
Biogen Idec Ma Inc. |
Nutrient monitoring and feedback control for increased bioproduct production
|
|
CN102149724B
(zh)
*
|
2008-08-14 |
2014-04-09 |
健泰科生物技术公司 |
使用原地蛋白质置换离子交换膜层析清除污染物的方法
|
|
WO2010036443A1
(en)
|
2008-09-26 |
2010-04-01 |
Eureka Therapeutics, Inc. |
Cell lines and proteins with variant glycosylation pattern
|
|
AU2009307735B2
(en)
|
2008-10-20 |
2014-12-04 |
Abbvie Inc. |
Antibodies that bind to IL-12 and methods of purifying the same
|
|
KR20110071011A
(ko)
|
2008-10-20 |
2011-06-27 |
아보트 러보러터리즈 |
Ｉｌ-18에 결합하는 항체 및 이의 정제 방법
|
|
TWI610936B
(zh)
*
|
2008-10-20 |
2018-01-11 |
艾伯維有限公司 |
使用蛋白質ａ親和性層析進行抗體之分離及純化
|
|
TW201028433A
(en)
|
2008-10-20 |
2010-08-01 |
Abbott Lab |
Viral inactivation during purification of antibodies
|
|
US8058407B2
(en)
*
|
2008-10-31 |
2011-11-15 |
Wyeth Llc |
Purification of acidic proteins using ceramic hydroxyapatite chromatography
|
|
SG172004A1
(en)
*
|
2008-12-09 |
2011-07-28 |
Hoffmann La Roche |
Method for obtaining an excipient-free antibody solution
|
|
JP2012513425A
(ja)
|
2008-12-22 |
2012-06-14 |
エフ．ホフマン−ラ ロシュ アーゲー |
免疫グロブリンの精製
|
|
EP2373676B1
(en)
|
2009-01-08 |
2017-04-19 |
GE Healthcare BioProcess R&D AB |
Separation method using single polymer phase systems
|
|
WO2010102114A1
(en)
|
2009-03-05 |
2010-09-10 |
Biogen Idec Ma Inc. |
Purification of immunoglobulins
|
|
EP2412817B2
(en)
*
|
2009-03-27 |
2019-06-05 |
Asahi Kasei Medical Co., Ltd. |
Method for removing viruses in high-concentration monoclonal antibody solution
|
|
AR076288A1
(es)
|
2009-04-13 |
2011-06-01 |
Bristol Myers Squibb Co |
Purificacion de proteinas por precipitacion con citrato
|
|
AU2010240569A1
(en)
*
|
2009-04-20 |
2011-10-20 |
Pfizer Inc. |
Control of protein glycosylation and compositions and methods relating thereto
|
|
US8969043B2
(en)
*
|
2009-05-28 |
2015-03-03 |
Boehringer Ingelheim International Gmbh |
Method for a rational cell culturing process
|
|
EP2438185A4
(en)
*
|
2009-06-05 |
2016-10-05 |
Momenta Pharmaceuticals Inc |
METHODS FOR MODULATING FUCOSYLATION OF GLYCOPROTEINS
|
|
CN107043703B
(zh)
|
2009-07-06 |
2020-03-27 |
弗·哈夫曼-拉罗切有限公司 |
真核细胞的培养方法
|
|
BRPI1010119A2
(pt)
|
2009-07-24 |
2016-03-15 |
Hoffmann La Roche |
"método de produção de composição de anticorpo e uso de cromatografia de troca de íons analítica"
|
|
WO2011015926A1
(en)
|
2009-08-03 |
2011-02-10 |
Avesthagen Limited |
A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein
|
|
SG178276A1
(en)
|
2009-08-06 |
2012-03-29 |
Genentech Inc |
Method to improve virus removal in protein purification
|
|
WO2011019622A1
(en)
*
|
2009-08-14 |
2011-02-17 |
Genentech, Inc. |
Cell culture methods to make antibodies with enhanced adcc function
|
|
WO2011024025A1
(en)
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
|
KR101764449B1
(ko)
|
2009-09-01 |
2017-08-02 |
제넨테크, 인크. |
변형된 단백질 ａ 용리를 통한 증진된 단백질 정제
|
|
US9540426B2
(en)
|
2009-10-06 |
2017-01-10 |
Bristol-Myers Squibb Company |
Mammalian cell culture processes for protein production
|
|
EP3037104B1
(en)
*
|
2009-10-20 |
2020-05-27 |
AbbVie Inc. |
Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
|
|
EP2490780A4
(en)
*
|
2009-10-20 |
2014-04-09 |
Merck Sharp & Dohme |
USE OF A MIXED MODE CHROMATOGRAPHY FOR THE DETECTION AND PURIFICATION OF BASIC ANTIBODY PRODUCTS
|
|
US9096879B2
(en)
|
2009-11-24 |
2015-08-04 |
Biogen Ma Inc. |
Method of supplementing culture media to prevent undesirable amino acid substitutions
|
|
WO2011069056A2
(en)
|
2009-12-04 |
2011-06-09 |
Momenta Pharmaceuticals, Inc. |
Antennary fucosylation in glycoproteins from cho cells
|
|
US8277649B2
(en)
|
2009-12-14 |
2012-10-02 |
General Electric Company |
Membranes and associated methods for purification of antibodies
|
|
CA2784278C
(en)
*
|
2009-12-18 |
2019-02-26 |
Novartis Ag |
Wash solution and method for affinity chromatography
|
|
KR101405463B1
(ko)
*
|
2010-01-15 |
2014-06-27 |
그래핀스퀘어 주식회사 |
기체 및 수분 차단용 그래핀 보호막, 이의 형성 방법 및 그의 용도
|
|
CN102858988A
(zh)
*
|
2010-04-06 |
2013-01-02 |
赫里开发公司 |
通过使用具有递减极性的溶剂从含油材料连续提取油和蛋白质材料
|
|
US9921210B2
(en)
|
2010-04-07 |
2018-03-20 |
Momenta Pharmaceuticals, Inc. |
High mannose glycans
|
|
ES2533074T3
(es)
|
2010-04-26 |
2015-04-07 |
Novartis Ag |
Medio de cultivo celular mejorado
|
|
RU2577972C2
(ru)
|
2010-04-26 |
2016-03-20 |
Новартис Аг |
Способ получения рекомбинантного полипептида
|
|
PL2576580T3
(pl)
|
2010-05-28 |
2017-03-31 |
F.Hoffmann-La Roche Ag |
Zmniejszenie poziomu mleczanu i zwiększenie wytwarzania polipeptydu przez obniżenie poziomu ekspresji dehydrogenazy mleczanowej i kinazy dehydrogenazy pirogronianowej
|
|
WO2012019160A1
(en)
|
2010-08-05 |
2012-02-09 |
Amgen Inc. |
Dipeptides to enhance yield and viability from cell cultures
|
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
|
CA2810909A1
(en)
*
|
2010-09-20 |
2012-03-29 |
Abbvie Inc. |
Purification of antibodies using simulated moving bed chromatography
|
|
JP6023715B2
(ja)
*
|
2010-10-11 |
2016-11-09 |
アッヴィ・バハマズ・リミテッド |
タンパク質の精製方法
|
|
KR101898302B1
(ko)
|
2010-10-15 |
2018-09-13 |
제이씨알 파마 가부시키가이샤 |
당사슬의 비환원 말단이 만노오스 잔기인 당 단백질의 제조 방법
|
|
EP2450375A1
(en)
|
2010-11-09 |
2012-05-09 |
Sandoz Gmbh |
Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
|
|
US20120149878A1
(en)
*
|
2010-12-08 |
2012-06-14 |
Gillespie Ronald |
Protein purification
|
|
KR101574864B1
(ko)
|
2010-12-21 |
2015-12-11 |
에프. 호프만-라 로슈 아게 |
이소폼이 농축된 항체 제제 및 그의 제조 방법
|
|
WO2012120500A2
(en)
|
2011-03-06 |
2012-09-13 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
|
TR201810703T4
(tr)
|
2011-03-25 |
2018-08-27 |
Hoffmann La Roche |
Yeni protein saflaştırma yöntemleri.
|
|
EP2511293A1
(en)
|
2011-04-13 |
2012-10-17 |
LEK Pharmaceuticals d.d. |
A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
|
|
WO2012145682A1
(en)
|
2011-04-21 |
2012-10-26 |
Amgen Inc. |
A method for culturing mammalian cells to improve recombinant protein production
|
|
CN105189735B
(zh)
|
2011-04-29 |
2019-04-12 |
拜康研究有限公司 |
在培养期间减少乳酸累积的方法和生产多肽的方法
|
|
US20120283419A1
(en)
|
2011-05-03 |
2012-11-08 |
Avantor Performance Materials, Inc. |
Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
|
|
DK2707383T3
(en)
|
2011-05-13 |
2018-07-23 |
Biogen Ma Inc |
PROCEDURES FOR PREVENTION AND REMOVAL OF TRISULPHIDE BINDINGS
|
|
CA2838695C
(en)
|
2011-07-01 |
2017-02-14 |
Amgen Inc. |
Mammalian cell culture
|
|
WO2013006461A1
(en)
|
2011-07-01 |
2013-01-10 |
Biogen Idec Ma Inc. |
Cholesterol-based media supplementals for cell culture
|
|
EP2729561A4
(en)
|
2011-07-08 |
2015-06-24 |
Momenta Pharmaceuticals Inc |
CELL CULTURE METHOD
|
|
WO2013013013A2
(en)
|
2011-07-21 |
2013-01-24 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for producing modified glycoproteins
|
|
CA2851053A1
(en)
|
2011-10-19 |
2013-04-25 |
Roche Glycart Ag |
Separation method for fucosylated antibodies
|
|
US9334319B2
(en)
*
|
2012-04-20 |
2016-05-10 |
Abbvie Inc. |
Low acidic species compositions
|
|
WO2013176754A1
(en)
*
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
*
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|